Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Shares, par value US$0.001 per share
-
Shares outstanding
-
71,872,133
-
Total 13F shares
-
3,035,348
-
Share change
-
-6,275,957
-
Total reported value
-
$345,241,022
-
Price per share
-
$125.06
-
Number of holders
-
5
-
Value change
-
-$39,640,820
-
Number of sells
-
11
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q4 2023
As of 31 Dec 2023,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,035,348 shares.
The largest 5 holders included
ORBIMED ADVISORS LLC, Neumann Advisory Hong Kong Ltd, Financial Gravity Asset Management, Inc., Horizon Investments, LLC, and Transamerica Financial Advisors, Inc..
This page lists
5
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.